Mohammad Reza (Nima) Darbandi | Breast Cancer | Best Researcher Award

Posted on by ScienceFather

Mr. Mohammad Reza (Nima) Darbandi | Breast Cancer | Best Researcher Award

PhD candidate of University of Georgia, United States.

Nima Darbandi is a Ph.D. student in Computer Science at the University of Georgia, where he also serves as a research and teaching assistant. His research focuses on optimizing the llama.cpp framework and developing AI systems for domain detection using DNS logs. Nima has extensive experience in teaching subjects like Discrete Mathematics and Computer Networks. He has held various roles in the industry, including Linux Expert at Parspack Cloud Services, Consultant at Monenco Industry Group, and Chief Technical Officer at HamyarNet ISP. Nima’s research skills encompass AI, computer networks, and system administration, with a strong foundation in Network+, CCNA, and Linux Essentials. His contributions to artificial intelligence and disease treatment highlight his innovative approach and interdisciplinary expertise. He has been recognized with several awards, including the Outstanding Teaching Assistant Award from the University of Georgia.

Professional Profiles:

Education

Nima Darbandi is currently pursuing his Ph.D. in Computer Science at the University of Georgia, Athens, GA, USA, starting in the fall of 2022. He earned his M.S. in Information Technology from the Iran University of Science and Technology, Tehran, IRAN, where he conducted a dissertation titled “A New Method to Estimate QoE for Internet Users” from 2011 to 2015. Before that, he completed his B.S. in Information Technology at Shiraz University of Technology, Shiraz, IRAN, between 2006 and 2010.

Professional Experience

Nima Darbandi has a diverse professional background in both academia and industry. As a Research/Teaching Assistant at the University of Georgia, he worked on llama.cpp framework optimization and AI systems for DNS logs under Dr. Agrawal, Dr. Niu, and Dr. Perdisci from 2022 to 2024, while also teaching Discrete Mathematics and Computer Networks. In the industry, he served as a Linux Expert at Parspack Cloud Services in Tehran from 2021 to 2022, and as a Consultant for Monenco Industry Group from 2020 to 2022, where he developed a Dispatching System on CISCO telephony. Nima held the position of Chief Technical Officer at HamyarNet ISP from 2017 to 2020, overseeing ADSL and P2P wireless Internet services. He founded Puzzle Network Solutions, focusing on network services and devices, from 2014 to 2017, and was a Senior Manager at SabaNet ISP from 2009 to 2014. He also has extensive teaching experience, providing Network+, CCNA, Linux Essentials, and Computer Networking courses across several institutions in Shiraz from 2007 to 2018.

Research Interest

Nima Darbandi’s research interests lie primarily in the fields of computer science, information technology, and artificial intelligence. He is particularly focused on optimizing AI frameworks, such as llama.cpp, and utilizing AI for domain-specific applications like DNS log analysis. His work includes enhancing the quality of experience (QoE) for internet users, which was the subject of his M.S. dissertation. Nima is also interested in developing AI-driven solutions for early diagnosis and precision treatment in healthcare, as evidenced by his publication on AI breakthroughs in breast cancer treatment. Additionally, his research spans into network management, cloud hosting services, and cybersecurity, showcasing a broad interest in both theoretical and applied aspects of computing and technology.

Award and Honors

Nima Darbandi has received several awards and honors throughout his academic and professional career. In 2023, he was honored with the Outstanding Teaching Assistant Award from the University of Georgia, recognizing his excellence in teaching and support for students. In 2016, he received the Best Supporter and Advisor Token of Appreciation from Kavosh, highlighting his contributions and advisory role. Earlier, in 2013, he was awarded the Outstanding Network Expert Token of Appreciation from SabaNet ISP for his expertise and dedication in the field of network services. Additionally, in 2007, he secured the Third Rank Token of Appreciation from Shiraz University of Technology, acknowledging his academic achievements during his undergraduate studies. These accolades reflect his commitment to both teaching and technical proficiency.

 Research Skills

Nima Darbandi possesses a diverse set of research skills, honed through extensive academic and professional experiences. His expertise includes optimizing the llama.cpp framework and developing AI systems for domain detection using DNS logs. He is proficient in various aspects of computer networks, evidenced by his teaching roles in Discrete Mathematics and Computer Networks. His background in Linux, cloud hosting, and virtualization (VMware VCenter) further strengthens his technical prowess. Additionally, Nima has practical experience with Network+, CCNA, and Linux Essentials, reflecting his broad knowledge in networking and system administration. His research contributions in artificial intelligence, particularly in early diagnosis and precision treatment of diseases, underscore his interdisciplinary approach and innovation in the field.

 

 

Mohammed Kashani-Sabet | Oncology | Best Researcher Award

Posted on by ScienceFather

Dr. Mohammed Kashani-Sabet | Oncology | Best Researcher Award

Medical Director, Oncology Service Line, Sutter Health at California Pacific Medical Center Research Institute, United States.

Dr. Mohammed Kashani-Sabet is a distinguished medical professional with extensive expertise in dermatology and oncology. Holding multiple leadership positions, including Medical Director of the Oncology Service Line at Sutter Health and the Cancer Center at California Pacific Medical Center, he has made significant contributions to cancer research and treatment. Dr. Kashani-Sabet received his medical education from renowned institutions such as Harvard University and the State University of New York at Stony Brook. Throughout his career, he has been involved in groundbreaking research focused on melanoma, cutaneous T-cell lymphoma, targeted therapy, and tumor biomarkers. He has received numerous honors and awards for his contributions to the field, including the Clinical Career Development Award from the Dermatology Foundation and the Patients’ Choice Award by Sutter Medical Network. Dr. Kashani-Sabet’s dedication to improving patient care and advancing cancer treatment has earned him widespread recognition and respect in the medical community.

Professional Profiles:

Education:

Dr. Mohammed Kashani-Sabet embarked on his academic journey with a Bachelor’s degree in Biochemical Sciences from Harvard University, followed by a Doctorate in Medicine from the State University of New York at Stony Brook. After completing his medical education, he undertook an internship in Internal Medicine and residency in Dermatology at the State University of New York at Stony Brook and the University of California, San Francisco (UCSF) respectively. Dr. Kashani-Sabet further honed his expertise through a post-doctoral fellowship in Cutaneous Oncology at UCSF’s Department of Dermatology and Division of Hematology/Oncology. This comprehensive educational background laid a robust foundation for his subsequent career as a renowned physician and researcher in the field of dermatology and oncology.

Professional Experience:

Dr. Mohammed Kashani-Sabet has held several prestigious positions throughout his career, demonstrating his leadership and expertise in the field of dermatology and oncology. Currently, he serves as the Medical Director of the Oncology Service Line at Sutter Health and as the Medical Director of the Cancer Center at California Pacific Medical Center. Additionally, he holds the position of Medical Director of the Center for Melanoma Research and Treatment at Sutter West Bay Medical Group, Sutter Pacific Medical Foundation, and California Pacific Medical Center. Dr. Kashani-Sabet also contributes significantly to research as a Senior Scientist at the California Pacific Medical Center Research Institute. His extensive professional experience spans over two decades and encompasses various roles in academia, clinical practice, and administrative leadership within prestigious institutions such as the University of California, San Francisco (UCSF) and the California Pacific Medical Center.

Research Focus:

Dr. Mohammed Kashani-Sabet’s research focus encompasses a broad spectrum of topics within dermatology and oncology, with a particular emphasis on melanoma and cutaneous T-cell lymphoma. His work includes investigating novel targeted therapies, such as ribozymes and siRNAs, for these malignancies. Additionally, he explores tumor metastasis, prognostic modeling, and tumor biomarkers to advance our understanding of these diseases and improve patient outcomes. Dr. Kashani-Sabet’s research efforts aim to translate scientific discoveries into clinical applications, with the ultimate goal of developing more effective treatments and interventions for patients with melanoma and cutaneous T-cell lymphoma.

Research Interest:

Dr. Mohammed Kashani-Sabet possesses a diverse set of research skills honed over years of experience in dermatology and oncology. His expertise includes clinical research, where he designs and conducts studies to evaluate novel therapies for melanoma and cutaneous T-cell lymphoma. In the laboratory, he is skilled in various techniques such as PCR, DNA sequencing, and gene expression analysis, essential for basic and translational research. Dr. Kashani-Sabet also excels in data analysis, utilizing statistical methods and software to interpret clinical and experimental data effectively. With a track record of publishing research findings in peer-reviewed journals, he demonstrates proficiency in scientific writing and manuscript preparation. Additionally, his ability to write grant proposals and collaborate with interdisciplinary teams underscores his commitment to advancing dermatologic oncology research and improving patient care.

Award and Honors:

Dr. Mohammed Kashani-Sabet has been recognized with numerous awards and honors throughout his career, reflecting his exceptional contributions to dermatologic oncology research and patient care. Among these accolades are the Clinical Career Development Award from the Dermatology Foundation in 1997 and the Herschel and Diana Zackheim Endowed Chair in Cutaneous Oncology in the same year. His dedication to teaching and mentorship was acknowledged with the Teacher of the Year Award in 2004, bestowed upon him by the Dermatology Residents at UCSF. Notably, Dr. Kashani-Sabet received the Patients’ Choice Award in 2013 from the Sutter Medical Network for achieving high patient satisfaction scores. His humanitarian efforts were recognized with the Humanitarian Award by the Melanoma Research Foundation in 2014. Moreover, he holds the Chair in Melanoma Research and Treatment at California Pacific Medical Center since 2015, a testament to his leadership and contributions to the field.

Publications:

  1. Pan-Cancer Pharmacogenomic Analysis of Patient-Derived Tumor Cells Using Clinically Relevant Drug Exposures
    • Authors: Chang, S.H., Ice, R.J., Chen, M., … Soroceanu, L., McAllister, S.D.
    • Citations: 0
    • Year: 2023
  2. Early Detection and Prognostic Assessment of Cutaneous Melanoma: Consensus on Optimal Practice and the Role of Gene Expression Profile Testing
    • Authors: Kashani-Sabet, M., Leachman, S.A., Stein, J.A., … Venna, S., Kirkwood, J.M.
    • Citations: 6
    • Year: 2023
  3. Improving Selection for Sentinel Lymph Node Biopsy among Patients with Melanoma
    • Authors: Miller, J.R., Lo, S.N., Nosrati, M., … Scolyer, R.A., Kashani-Sabet, M.
    • Citations: 3
    • Year: 2023
  4. Erratum: Bromodomain inhibition overcomes treatment resistance in distinct molecular subtypes of melanoma
    • Authors: Dar, A.A., Bezrookove, V., Nosrati, M., … McAllister, S., Kashani-Sabet, M.
    • Citations: 0
    • Year: 2023
  5. Dual Targeting of EGFR and MTOR Pathways Inhibits Glioblastoma Growth by Modulating the Tumor Microenvironment
    • Authors: Sidorov, M., Dighe, P., Woo, R.W.L., … McAllister, S.D., Soroceanu, L.
    • Citations: 7
    • Year: 2023
  6. Extended long-term follow-up of metastatic melanoma patients treated with immunotherapy: late relapses and second primary melanomas
    • Authors: Minor, D.R., Kim, K.B., Karuturi, R.K.M., Kashani-Sabet, M.
    • Citations: 0
    • Year: 2023
  7. Lymphoscintigraphy Using Tilmanocept Detects Multiple Sentinel Lymph Nodes in Melanoma Patients
    • Authors: Balkin, D.M., Tranah, G.J., Wang, F., … Zager, J.S., Leong, S.P.
    • Citations: 0
    • Year: 2023
  8. BPTF promotes the progression of distinct subtypes of breast cancer and is a therapeutic target
    • Authors: Bezrookove, V., Khan, I.A., Nosrati, M., … Dar, A.A., Kashani-Sabet, M.
    • Citations: 3
    • Year: 2022
  9. Pitfalls and Rewards of Setting Up a Liquid Biopsy Approach for the Detection of Driver Mutations in Circulating Tumor DNAs: Our Institutional Experience
    • Authors: Chen, M., Jian, D., Sidorov, M., … McAllister, S.D., Desprez, P.-Y.
    • Citations: 2
    • Year: 2022
  10. Bromodomain inhibition overcomes treatment resistance in distinct molecular subtypes of melanoma
    • Authors: Dar, A.A., Bezrookove, V., Nosrati, M., … McAllister, S., Kashani-Sabet, M.
    • Citations: 3
    • Year: 2022